BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29411266)

  • 1. A Molecular Neurobiological Approach to Understanding the Aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease) with Treatment Implications.
    Monro JA; Puri BK
    Mol Neurobiol; 2018 Sep; 55(9):7377-7388. PubMed ID: 29411266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical analysis of the proposal of the Institute of Medicine to replace myalgic encephalomyelitis and chronic fatigue syndrome by a new diagnostic entity called systemic exertion intolerance disease.
    Twisk FN
    Curr Med Res Opin; 2015; 31(7):1333-47. PubMed ID: 25912615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
    Corbitt M; Eaton-Fitch N; Staines D; Cabanas H; Marshall-Gradisnik S
    BMC Neurol; 2019 Aug; 19(1):207. PubMed ID: 31445522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
    Holden S; Maksoud R; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 Jul; 18(1):290. PubMed ID: 32727475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Acute Exercise on Fatigue in People with ME/CFS/SEID: A Meta-analysis.
    Loy BD; O'Connor PJ; Dishman RK
    Med Sci Sports Exerc; 2016 Oct; 48(10):2003-12. PubMed ID: 27187093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Lim EJ; Son CG
    J Transl Med; 2020 Jul; 18(1):289. PubMed ID: 32727489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suggested pathology of systemic exertion intolerance disease: Impairment of the E
    Bohne VJB; Bohne Ø
    Med Hypotheses; 2019 Sep; 130():109260. PubMed ID: 31383326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.
    Jinushi R; Masuda S; Tanisaka Y; Nishiguchi S; Shionoya K; Sato R; Sugimoto K; Shin T; Shiomi R; Fujita A; Mizuide M; Ryozawa S
    J Transl Med; 2023 Jun; 21(1):398. PubMed ID: 37337273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allostatic overload in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Arroll MA
    Med Hypotheses; 2013 Sep; 81(3):506-8. PubMed ID: 23850395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
    Twisk FN; Maes M
    Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new look at chronic fatigue syndrome/myalgic encephalomyelitis.
    Gibson I
    J Clin Pathol; 2007 Feb; 60(2):120-1. PubMed ID: 16935965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems in defining post-exertional malaise.
    Jason LA; Evans M; So S; Scott J; Brown A
    J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Grach SL; Seltzer J; Chon TY; Ganesh R
    Mayo Clin Proc; 2023 Oct; 98(10):1544-1551. PubMed ID: 37793728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
    Ariza ME
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Fatigue Syndrome versus Systemic Exertion Intolerance Disease.
    Jason LA; Sunnquist M; Brown A; Newton JL; Strand EB; Vernon SD
    Fatigue; 2015 Jul; 3(3):127-141. PubMed ID: 26345409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From neurasthenia to post-exertion disease: Evolution of the diagnostic criteria of chronic fatigue syndrome/myalgic encephalomyelitis].
    Murga Í; Lafuente JV
    Aten Primaria; 2019 Nov; 51(9):579-585. PubMed ID: 31182238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.